Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Research Biosimilar

Research Grade Afelimomab (DHB94405)

Host species:Mouse
Isotype:F(ab')2-G3-kappa
Applications:Research Grade Biosimilar
Expression system:Mammalian Cells
Overview

Catalog No.

DHB94405

Expression system

Mammalian Cells

Species reactivity

Human

Host species

Mouse

Isotype

F(ab')2-G3-kappa

Clonality

Monoclonal

Target

TNF, Tumor necrosis factor ligand superfamily member 2, N-terminal fragment, ICD2, NTF, TNF-a, TNF-alpha, Tumor necrosis factor, TNFSF2, TNFA, Cachectin, ICD1

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

P01375

Applications

Research Grade Biosimilar

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Alternative Names

MAK-195F, CAS: 156227-98-4

Clone ID

Afelimomab

Data Image
References

[Anti-inflammatory therapy in sepsis], PMID: 12883811

[Anti-inflammatory treatment in sepsis], PMID: 12430058

A multicenter, open-label, prospective, randomized, dose-ranging pharmacokinetic study of the anti-TNF-alpha antibody afelimomab in patients with sepsis syndrome, PMID: 11534565

Afelimomab led to a modest mortality benefit in patients with severe sepsis and elevated interleukin-6 levels, PMID: 16277704

Afelimomab, PMID: 10829362

Afelimomab-another therapeutic option in sepsis therapy?, PMID: 15640652

Anti-tumor necrosis factor therapy in sepsis: update on clinical trials and lessons learned, PMID: 11445746

Efficacy and safety of the monoclonal anti-tumor necrosis factor antibody F(ab')2 fragment afelimomab in patients with severe sepsis and elevated interleukin-6 levels, PMID: 15640628

Emerging drugs for the treatment of sepsis, PMID: 22780561

Endothelin in septic patients: effects on cardiovascular and renal function and its relationship to proinflammatory cytokines, PMID: 10890632

MONARCS: statistical or clinical meaning?, PMID: 16148507

Randomized, placebo-controlled trial of the anti-tumor necrosis factor antibody fragment afelimomab in hyperinflammatory response during severe sepsis: The RAMSES Study, PMID: 11373466

Whose loss is it? Human electrophysiological correlates of non-self reward processing, PMID: 19191194

Datasheet

Document Download

Research Grade Afelimomab.pdf

 

$ 426
Product specifications
100 μg 426 1 mg 1704

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Research Grade Afelimomab [DHB94405]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2024 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only